25 XP   0   0   10

Nectar Lifesciences Limited
Buy, Hold or Sell?

Let's analyse Nectar Lifesciences Limited together

PenkeI guess you are interested in Nectar Lifesciences Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Nectar Lifesciences Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Nectar Lifesciences Limited

I send you an email if I find something interesting about Nectar Lifesciences Limited.

Quick analysis of Nectar Lifesciences Limited (30 sec.)










What can you expect buying and holding a share of Nectar Lifesciences Limited? (30 sec.)

How much money do you get?

How much money do you get?
INR0.00
When do you have the money?
1 year
How often do you get paid?
90.0%

What is your share worth?

Current worth
INR47.47
Expected worth in 1 year
INR43.31
How sure are you?
70.0%

+ What do you gain per year?

Total Gains per Share
INR-4.16
Return On Investment
-13.8%

For what price can you sell your share?

Current Price per Share
INR30.11
Expected price per share
INR27.80 - INR45.70
How sure are you?
50%

1. Valuation of Nectar Lifesciences Limited (5 min.)




Live pricePrice per Share (EOD)

INR30.11

Intrinsic Value Per Share

INR-51.64 - INR73.90

Total Value Per Share

INR-4.17 - INR121.37

2. Growth of Nectar Lifesciences Limited (5 min.)




Is Nectar Lifesciences Limited growing?

Current yearPrevious yearGrowGrow %
How rich?$127.7m$130.5m-$2.7m-2.2%

How much money is Nectar Lifesciences Limited making?

Current yearPrevious yearGrowGrow %
Making money-$2.9m$3m-$5.9m-203.6%
Net Profit Margin-1.6%1.5%--

How much money comes from the company's main activities?

3. Financial Health of Nectar Lifesciences Limited (5 min.)




4. Comparing to competitors in the Drug Manufacturers - Major industry (5 min.)




  Industry Rankings (Drug Manufacturers - Major)  


Richest
#6 / 11

Most Profit
#11 / 11

What can you expect buying and holding a share of Nectar Lifesciences Limited? (5 min.)

Welcome investor! Nectar Lifesciences Limited's management wants to use your money to grow the business. In return you get a share of Nectar Lifesciences Limited.

What can you expect buying and holding a share of Nectar Lifesciences Limited?

First you should know what it really means to hold a share of Nectar Lifesciences Limited. And how you can make/lose money.

Speculation

The Price per Share of Nectar Lifesciences Limited is INR30.11. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Nectar Lifesciences Limited.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Nectar Lifesciences Limited, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR47.47. Based on the TTM, the Book Value Change Per Share is INR-1.04 per quarter. Based on the YOY, the Book Value Change Per Share is INR1.15 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Nectar Lifesciences Limited.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps-0.010.0%-0.010.0%0.010.0%0.000.0%0.020.1%
Usd Book Value Change Per Share-0.010.0%-0.010.0%0.010.0%0.000.0%0.060.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.010.0%-0.010.0%0.010.0%0.000.0%0.060.2%
Usd Price Per Share0.19-0.19-0.29-0.21-0.30-
Price to Earnings Ratio-14.71--14.71-21.53-3.23-7.87-
Price-to-Total Gains Ratio-15.26--15.26-20.05-2.79-1.92-
Price to Book Ratio0.33-0.33-0.50-0.35-0.55-
Price-to-Total Gains Ratio-15.26--15.26-20.05-2.79-1.92-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.36132
Number of shares2767
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.010.00
Usd Total Gains Per Share-0.010.00
Gains per Quarter (2767 shares)-34.513.19
Gains per Year (2767 shares)-138.0512.78
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-138-148673
20-276-286111416
30-414-424172129
40-552-562232842
50-690-700293555
60-828-838344268
70-966-976404981
80-1104-1114465694
90-1242-12525263107
100-1381-13905770120

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%8.02.00.080.0%8.02.00.080.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%7.03.00.070.0%7.03.00.070.0%
Dividend per Share0.00.01.00.0%2.00.01.066.7%4.00.01.080.0%9.00.01.090.0%9.00.01.090.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%7.03.00.070.0%7.03.00.070.0%

Fundamentals of Nectar Lifesciences Limited

About Nectar Lifesciences Limited

Nectar Lifesciences Limited manufactures and sells pharmaceutical products in India and internationally. The company offers contract research and manufacturing services, including process development and optimization, process scale up and validation, preparation and international submission of drug master files and certificates of suitability, multi kilo pilot plant production, bulk production, and chiral resolution; and chemical and analytical development, as well as analytical, manufacturing, and engineering consulting services. Its active pharmaceutical ingredients and intermediates comprise cefixime trihydrate, cefuroxime axetil, cefpodoxime proxetil, cefdinir, ceftriaxone sodium, cefotaxime sodium, cefuroxime sodium, ceftazidime, cefepime HCl, cephalothin, cefazolin sodium, cefprozil, cefoperzone sodium, cefpirome sulphate, and cefoxitin sodium. The company also offers contract manufacturing for finished dosage forms, such as tablets, capsules, dry powder oral suspensions, and granules and injectable for cephalosporins. In addition, it provides a range of diagnostics products; and empty hard gelatin capsules. Further, the company menthol crystals, menthol powders and flakes, peppermint oils, dementholized peppermint oils, and menthone; CIS-3 hexenol, CIS-3-hexenol acetate/leaf acetate, and CIS-3-hexenol butyrate; mentha piperita oils, spearmint oils, distilled mentha oils/commint oils, distilled menthofuran, limonene, 3-octanol, terpenes, alpha pinene, beta pinene, 1.8 cineol, and ISO menthol; and menthone glycerol ketal, menthyl acetate, menthyl lactate, terpineol BP/USP/perfumery, pine oils, terpinolene, terpinen 4 ol, terpinyl acetate, lavendor ketone (3-Octanone), 3 menthyl cyclohexenone, and gamma terpinene. Nectar Lifesciences Limited was founded in 1995 and is headquartered in New Delhi, India.

Fundamental data was last updated by Penke on 2024-03-26 11:53:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Nectar Lifesciences Limited.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Nectar Lifesciences Limited earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Nectar Lifesciences Limited to the Drug Manufacturers - Major industry mean.
  • A Net Profit Margin of -1.6% means that ₹-0.02 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Nectar Lifesciences Limited:

  • The MRQ is -1.6%. The company is making a loss. -1
  • The TTM is -1.6%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ-1.6%TTM-1.6%0.0%
TTM-1.6%YOY1.5%-3.1%
TTM-1.6%5Y-0.4%-1.2%
5Y-0.4%10Y1.5%-1.9%
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.6%10.6%-12.2%
TTM-1.6%10.6%-12.2%
YOY1.5%13.3%-11.8%
5Y-0.4%10.2%-10.6%
10Y1.5%10.1%-8.6%
1.1.2. Return on Assets

Shows how efficient Nectar Lifesciences Limited is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Nectar Lifesciences Limited to the Drug Manufacturers - Major industry mean.
  • -1.1% Return on Assets means that Nectar Lifesciences Limited generated ₹-0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Nectar Lifesciences Limited:

  • The MRQ is -1.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -1.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-1.1%TTM-1.1%0.0%
TTM-1.1%YOY1.0%-2.2%
TTM-1.1%5Y0.0%-1.1%
5Y0.0%10Y1.1%-1.2%
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.1%8.3%-9.4%
TTM-1.1%8.3%-9.4%
YOY1.0%9.5%-8.5%
5Y0.0%9.7%-9.7%
10Y1.1%8.3%-7.2%
1.1.3. Return on Equity

Shows how efficient Nectar Lifesciences Limited is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Nectar Lifesciences Limited to the Drug Manufacturers - Major industry mean.
  • -2.3% Return on Equity means Nectar Lifesciences Limited generated ₹-0.02 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Nectar Lifesciences Limited:

  • The MRQ is -2.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -2.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-2.3%TTM-2.3%0.0%
TTM-2.3%YOY2.3%-4.6%
TTM-2.3%5Y0.0%-2.3%
5Y0.0%10Y3.0%-3.0%
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.3%12.6%-14.9%
TTM-2.3%12.6%-14.9%
YOY2.3%12.3%-10.0%
5Y0.0%16.3%-16.3%
10Y3.0%13.7%-10.7%

1.2. Operating Efficiency of Nectar Lifesciences Limited.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Nectar Lifesciences Limited is operating .

  • Measures how much profit Nectar Lifesciences Limited makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Nectar Lifesciences Limited to the Drug Manufacturers - Major industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Nectar Lifesciences Limited:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y3.1%-3.1%
5Y3.1%10Y7.0%-3.9%
1.2.2. Operating Ratio

Measures how efficient Nectar Lifesciences Limited is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Major industry mean).
  • An Operation Ratio of 0.86 means that the operating costs are ₹0.86 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Nectar Lifesciences Limited:

  • The MRQ is 0.865. The company is less efficient in keeping operating costs low.
  • The TTM is 0.865. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.865TTM0.8650.000
TTM0.865YOY0.821+0.044
TTM0.8655Y1.215-0.350
5Y1.21510Y1.431-0.216
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8650.497+0.368
TTM0.8650.497+0.368
YOY0.8210.469+0.352
5Y1.2150.813+0.402
10Y1.4311.171+0.260

1.3. Liquidity of Nectar Lifesciences Limited.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Nectar Lifesciences Limited is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Major industry mean).
  • A Current Ratio of 1.38 means the company has ₹1.38 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Nectar Lifesciences Limited:

  • The MRQ is 1.382. The company is just able to pay all its short-term debts.
  • The TTM is 1.382. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.382TTM1.3820.000
TTM1.382YOY1.350+0.032
TTM1.3825Y1.271+0.111
5Y1.27110Y1.226+0.045
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3822.176-0.794
TTM1.3822.176-0.794
YOY1.3502.121-0.771
5Y1.2711.911-0.640
10Y1.2261.566-0.340
1.3.2. Quick Ratio

Measures if Nectar Lifesciences Limited is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Nectar Lifesciences Limited to the Drug Manufacturers - Major industry mean.
  • A Quick Ratio of 0.33 means the company can pay off ₹0.33 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Nectar Lifesciences Limited:

  • The MRQ is 0.334. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.334. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.334TTM0.3340.000
TTM0.334YOY0.462-0.128
TTM0.3345Y0.382-0.048
5Y0.38210Y0.403-0.021
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3341.584-1.250
TTM0.3341.584-1.250
YOY0.4621.767-1.305
5Y0.3821.430-1.048
10Y0.4031.030-0.627

1.4. Solvency of Nectar Lifesciences Limited.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Nectar Lifesciences Limited assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Nectar Lifesciences Limited to Drug Manufacturers - Major industry mean.
  • A Debt to Asset Ratio of 0.51 means that Nectar Lifesciences Limited assets are financed with 51.4% credit (debt) and the remaining percentage (100% - 51.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Nectar Lifesciences Limited:

  • The MRQ is 0.514. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.514. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.514TTM0.5140.000
TTM0.514YOY0.545-0.031
TTM0.5145Y0.555-0.041
5Y0.55510Y0.586-0.032
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5140.402+0.112
TTM0.5140.402+0.112
YOY0.5450.403+0.142
5Y0.5550.433+0.122
10Y0.5860.486+0.100
1.4.2. Debt to Equity Ratio

Measures if Nectar Lifesciences Limited is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Nectar Lifesciences Limited to the Drug Manufacturers - Major industry mean.
  • A Debt to Equity ratio of 105.6% means that company has ₹1.06 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Nectar Lifesciences Limited:

  • The MRQ is 1.056. The company is able to pay all its debts with equity. +1
  • The TTM is 1.056. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.056TTM1.0560.000
TTM1.056YOY1.198-0.141
TTM1.0565Y1.254-0.197
5Y1.25410Y1.436-0.182
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0560.516+0.540
TTM1.0560.516+0.540
YOY1.1980.556+0.642
5Y1.2540.588+0.666
10Y1.4360.857+0.579

2. Market Valuation of Nectar Lifesciences Limited

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Nectar Lifesciences Limited generates.

  • Above 15 is considered overpriced but always compare Nectar Lifesciences Limited to the Drug Manufacturers - Major industry mean.
  • A PE ratio of -14.71 means the investor is paying ₹-14.71 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Nectar Lifesciences Limited:

  • The EOD is -27.923. Based on the earnings, the company is expensive. -2
  • The MRQ is -14.708. Based on the earnings, the company is expensive. -2
  • The TTM is -14.708. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-27.923MRQ-14.708-13.215
MRQ-14.708TTM-14.7080.000
TTM-14.708YOY21.533-36.241
TTM-14.7085Y3.233-17.941
5Y3.23310Y7.872-4.639
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
EOD-27.92316.860-44.783
MRQ-14.70810.473-25.181
TTM-14.70810.473-25.181
YOY21.53313.672+7.861
5Y3.2339.785-6.552
10Y7.8729.992-2.120
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Nectar Lifesciences Limited:

  • The EOD is 6.518. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 3.433. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 3.433. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD6.518MRQ3.433+3.085
MRQ3.433TTM3.4330.000
TTM3.433YOY7.701-4.268
TTM3.4335Y-5.658+9.092
5Y-5.65810Y2.202-7.860
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
EOD6.51847.529-41.011
MRQ3.43317.381-13.948
TTM3.43317.381-13.948
YOY7.70120.356-12.655
5Y-5.65814.021-19.679
10Y2.2026.307-4.105
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Nectar Lifesciences Limited is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Major industry mean).
  • A PB ratio of 0.33 means the investor is paying ₹0.33 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Nectar Lifesciences Limited:

  • The EOD is 0.634. Based on the equity, the company is cheap. +2
  • The MRQ is 0.334. Based on the equity, the company is cheap. +2
  • The TTM is 0.334. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.634MRQ0.334+0.300
MRQ0.334TTM0.3340.000
TTM0.334YOY0.496-0.162
TTM0.3345Y0.353-0.019
5Y0.35310Y0.551-0.198
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
EOD0.6342.363-1.729
MRQ0.3341.350-1.016
TTM0.3341.350-1.016
YOY0.4961.439-0.943
5Y0.3531.472-1.119
10Y0.5512.335-1.784
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Nectar Lifesciences Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---1.039-1.0390%1.154-190%0.053-2064%4.747-122%
Book Value Per Share--47.47147.4710%48.511-2%48.656-2%45.948+3%
Current Ratio--1.3821.3820%1.350+2%1.271+9%1.226+13%
Debt To Asset Ratio--0.5140.5140%0.545-6%0.555-7%0.586-12%
Debt To Equity Ratio--1.0561.0560%1.198-12%1.254-16%1.436-26%
Dividend Per Share----0%0.046-100%0.043-100%0.072-100%
Eps---1.078-1.0780%1.117-197%0.062-1830%1.325-181%
Free Cash Flow Per Share--4.6194.6190%3.123+48%5.307-13%4.798-4%
Free Cash Flow To Equity Per Share---3.656-3.6560%-2.200-40%-1.350-63%-1.005-73%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--73.895--------
Intrinsic Value_10Y_min---51.638--------
Intrinsic Value_1Y_max--5.772--------
Intrinsic Value_1Y_min--0.521--------
Intrinsic Value_3Y_max--18.587--------
Intrinsic Value_3Y_min---3.358--------
Intrinsic Value_5Y_max--32.903--------
Intrinsic Value_5Y_min---12.604--------
Market Cap6752498469.120+47%3556779333.1203556779333.1200%5393476857.600-34%3834862963.200-7%5522426928.000-36%
Net Profit Margin---0.016-0.0160%0.015-206%-0.004-78%0.015-206%
Operating Margin----0%-0%0.031-100%0.070-100%
Operating Ratio--0.8650.8650%0.821+5%1.215-29%1.431-40%
Pb Ratio0.634+47%0.3340.3340%0.496-33%0.353-5%0.551-39%
Pe Ratio-27.923-90%-14.708-14.7080%21.533-168%3.233-555%7.872-287%
Price Per Share30.110+47%15.86015.8600%24.050-34%17.100-7%24.625-36%
Price To Free Cash Flow Ratio6.518+47%3.4333.4330%7.701-55%-5.658+265%2.202+56%
Price To Total Gains Ratio-28.968-90%-15.259-15.2590%20.048-176%2.790-647%1.919-895%
Quick Ratio--0.3340.3340%0.462-28%0.382-13%0.403-17%
Return On Assets---0.011-0.0110%0.010-205%0.000-97%0.011-197%
Return On Equity---0.023-0.0230%0.023-199%0.000-4885%0.030-175%
Total Gains Per Share---1.039-1.0390%1.200-187%0.096-1180%4.819-122%
Usd Book Value--127751400.000127751400.0000%130548600.000-2%130939584.000-2%123651888.000+3%
Usd Book Value Change Per Share---0.012-0.0120%0.014-190%0.001-2064%0.057-122%
Usd Book Value Per Share--0.5700.5700%0.582-2%0.584-2%0.551+3%
Usd Dividend Per Share----0%0.001-100%0.001-100%0.001-100%
Usd Eps---0.013-0.0130%0.013-197%0.001-1830%0.016-181%
Usd Free Cash Flow--12430920.00012430920.0000%8404200.000+48%14281512.000-13%12913200.000-4%
Usd Free Cash Flow Per Share--0.0550.0550%0.037+48%0.064-13%0.058-4%
Usd Free Cash Flow To Equity Per Share---0.044-0.0440%-0.026-40%-0.016-63%-0.012-73%
Usd Market Cap81029981.629+47%42681351.99742681351.9970%64721722.291-34%46018355.558-7%66269123.136-36%
Usd Price Per Share0.361+47%0.1900.1900%0.289-34%0.205-7%0.296-36%
Usd Profit---2901960.000-2901960.0000%3005520.000-197%167736.000-1830%3566268.000-181%
Usd Revenue--182840280.000182840280.0000%200259840.000-9%237266736.000-23%223263444.000-18%
Usd Total Gains Per Share---0.012-0.0120%0.014-187%0.001-1180%0.058-122%
 EOD+4 -4MRQTTM+0 -0YOY+10 -245Y+7 -2810Y+10 -25

3.2. Fundamental Score

Let's check the fundamental score of Nectar Lifesciences Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-27.923
Price to Book Ratio (EOD)Between0-10.634
Net Profit Margin (MRQ)Greater than0-0.016
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.334
Current Ratio (MRQ)Greater than11.382
Debt to Asset Ratio (MRQ)Less than10.514
Debt to Equity Ratio (MRQ)Less than11.056
Return on Equity (MRQ)Greater than0.15-0.023
Return on Assets (MRQ)Greater than0.05-0.011
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Nectar Lifesciences Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5034.301
Ma 20Greater thanMa 5033.134
Ma 50Greater thanMa 10035.597
Ma 100Greater thanMa 20032.640
OpenGreater thanClose30.150
Total3/5 (60.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-03-312020-03-312021-03-312022-03-312023-03-31
Operating Income  2,011,390-421,6501,589,740-1,342,980246,760768,9601,015,720-1,067,700-51,980



Latest Balance Sheet

Balance Sheet of 2023-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets21,892,110
Total Liabilities11,246,160
Total Stockholder Equity10,645,950
 As reported
Total Liabilities 11,246,160
Total Stockholder Equity+ 10,645,950
Total Assets = 21,892,110

Assets

Total Assets21,892,110
Total Current Assets12,311,830
Long-term Assets0
Total Current Assets
Cash And Cash Equivalents 175,520
Short-term Investments 3,140
Net Receivables 2,796,070
Inventory 7,315,150
Other Current Assets 368,250
Total Current Assets  (as reported)12,311,830
Total Current Assets  (calculated)10,658,130
+/- 1,653,700
Long-term Assets
Property Plant Equipment 6,904,280
Intangible Assets 493,290
Long-term Assets  (as reported)0
Long-term Assets  (calculated)7,397,570
+/- 7,397,570

Liabilities & Shareholders' Equity

Total Current Liabilities8,909,270
Long-term Liabilities0
Total Stockholder Equity10,645,950
Total Current Liabilities
Short-term Debt 4,589,130
Total Current Liabilities  (as reported)8,909,270
Total Current Liabilities  (calculated)4,589,130
+/- 4,320,140
Long-term Liabilities
Long term Debt Total 2,264,720
Long term Debt 2,261,630
Capital Lease Obligations Min Short Term Debt-4,589,130
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)-62,780
+/- 62,780
Total Stockholder Equity
Common Stock224,260
Retained Earnings 7,090,680
Capital Surplus 3,287,980
Other Stockholders Equity 43,030
Total Stockholder Equity (as reported)10,645,950
Total Stockholder Equity (calculated)10,645,950
+/-0
Other
Cash And Equivalents10
Cash and Short Term Investments 178,670
Common Stock Shares Outstanding 224,261
Liabilities and Stockholders Equity 21,892,110
Net Working Capital 3,402,560



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-31
> Total Assets 
23,940,660
24,296,880
25,563,320
25,809,110
27,238,200
27,049,880
26,333,080
23,881,140
23,908,320
21,892,110
21,892,11023,908,32023,881,14026,333,08027,049,88027,238,20025,809,11025,563,32024,296,88023,940,660
   > Total Current Assets 
12,373,350
13,690,110
14,644,160
14,958,570
16,606,070
16,690,300
16,151,580
12,388,280
13,548,490
12,311,830
12,311,83013,548,49012,388,28016,151,58016,690,30016,606,07014,958,57014,644,16013,690,11012,373,350
       Cash And Cash Equivalents 
99,780
-10
-10
131,810
-10
212,890
212,935
238,650
157,790
175,520
175,520157,790238,650212,935212,890-10131,810-10-1099,780
       Short-term Investments 
3,140
4,350
5,230
4,080
5,100
5,060
1,660
4,570
4,600
3,140
3,1404,6004,5701,6605,0605,1004,0805,2304,3503,140
       Net Receivables 
4,564,620
4,464,960
4,914,470
4,997,300
6,119,700
5,587,320
3,958,720
3,748,260
4,469,780
2,796,070
2,796,0704,469,7803,748,2603,958,7205,587,3206,119,7004,997,3004,914,4704,464,9604,564,620
       Inventory 
7,584,270
8,493,600
8,889,690
9,108,820
9,175,080
9,733,700
10,080,850
6,553,220
7,212,600
7,315,150
7,315,1507,212,6006,553,22010,080,8509,733,7009,175,0809,108,8208,889,6908,493,6007,584,270
       Other Current Assets 
121,540
63,480
62,470
72,780
99,780
144,130
109,960
69,780
66,180
368,250
368,25066,18069,780109,960144,13099,78072,78062,47063,480121,540
   > Long-term Assets 
0
0
0
10,820,460
10,632,130
10,359,580
10,181,500
0
0
0
00010,181,50010,359,58010,632,13010,820,460000
       Property Plant Equipment 
10,698,070
10,250,430
9,369,360
9,259,110
9,062,170
8,851,860
8,606,550
8,321,530
7,651,750
6,904,280
6,904,2807,651,7508,321,5308,606,5508,851,8609,062,1709,259,1109,369,36010,250,43010,698,070
       Long Term Investments 
500
1,500
2,700
2,700
0
0
0
0
0
0
0000002,7002,7001,500500
       Intangible Assets 
0
797,560
679,950
574,430
459,240
391,820
391,910
383,640
430,210
493,290
493,290430,210383,640391,910391,820459,240574,430679,950797,5600
       Long-term Assets Other 
0
0
0
2,170
5,000
4,990
5,020
0
0
0
0005,0204,9905,0002,170000
> Total Liabilities 
14,670,040
15,276,590
16,022,510
15,742,350
16,651,600
15,998,270
14,971,830
13,260,840
13,029,270
11,246,160
11,246,16013,029,27013,260,84014,971,83015,998,27016,651,60015,742,35016,022,51015,276,59014,670,040
   > Total Current Liabilities 
11,260,660
11,562,610
12,399,490
12,786,590
13,093,210
12,999,050
12,478,910
11,873,920
10,038,330
8,909,270
8,909,27010,038,33011,873,92012,478,91012,999,05013,093,21012,786,59012,399,49011,562,61011,260,660
       Short-term Debt 
8,584,180
5,952,980
6,272,430
6,303,410
6,340,830
6,359,690
6,197,130
7,120,040
5,027,690
4,589,130
4,589,1305,027,6907,120,0406,197,1306,359,6906,340,8306,303,4106,272,4305,952,9808,584,180
       Short Long Term Debt 
8,584,180
9,247,770
9,621,100
8,781,050
7,349,780
7,378,610
6,572,820
0
0
0
0006,572,8207,378,6107,349,7808,781,0509,621,1009,247,7708,584,180
       Accounts payable 
4,400,610
4,555,770
4,967,810
5,280,980
5,394,240
4,836,740
5,271,450
0
0
0
0005,271,4504,836,7405,394,2405,280,9804,967,8104,555,7704,400,610
       Other Current Liabilities 
465,200
333,900
112,480
187,200
230,280
664,480
529,430
0
0
0
000529,430664,480230,280187,200112,480333,900465,200
   > Long-term Liabilities 
0
0
0
2,955,770
3,558,400
2,999,200
2,492,930
0
0
0
0002,492,9302,999,2003,558,4002,955,770000
       Long term Debt Total 
0
2,655,290
2,453,970
1,638,000
2,200,760
1,655,900
1,214,820
1,282,380
2,910,750
2,264,720
2,264,7202,910,7501,282,3801,214,8201,655,9002,200,7601,638,0002,453,9702,655,2900
       Capital Lease Obligations 
0
0
0
0
8,300
6,850
0
0
0
0
00006,8508,3000000
       Long-term Liabilities Other 
0
0
0
185,780
173,800
119,230
22,880
0
0
0
00022,880119,230173,800185,780000
       Deferred Long Term Liability 
80
359,120
0
0
0
0
0
0
0
0
00000000359,12080
> Total Stockholder Equity
9,270,620
9,020,290
9,540,810
10,066,760
10,586,600
11,051,610
11,361,250
10,620,300
10,879,050
10,645,950
10,645,95010,879,05010,620,30011,361,25011,051,61010,586,60010,066,7609,540,8109,020,2909,270,620
   Common Stock
224,260
224,260
224,260
224,260
224,260
224,260
224,260
224,260
224,260
224,260
224,260224,260224,260224,260224,260224,260224,260224,260224,260224,260
   Retained Earnings 
5,758,380
6,067,240
6,028,570
6,554,520
7,074,360
7,539,370
7,849,010
7,108,060
7,366,810
7,090,680
7,090,6807,366,8107,108,0607,849,0107,539,3707,074,3606,554,5206,028,5706,067,2405,758,380
   Capital Surplus 
0
3,287,980
3,287,980
3,287,980
3,287,980
3,287,980
3,287,980
3,287,980
3,287,980
3,287,980
3,287,9803,287,9803,287,9803,287,9803,287,9803,287,9803,287,9803,287,9803,287,9800
   Treasury Stock0000000000
   Other Stockholders Equity 
0
10
0
0
0
10,827,350
0
0
0
43,030
43,03000010,827,350000100



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2023-03-31)

Gross Profit (+$)
totalRevenue15,236,690
Cost of Revenue-13,174,020
Gross Profit2,062,6702,062,670
 
Operating Income (+$)
Gross Profit2,062,670
Operating Expense-0
Operating Income-51,9802,062,670
 
Operating Expense (+$)
Research Development0
Selling General Administrative1,532,600
Selling And Marketing Expenses0
Operating Expense01,532,600
 
Net Interest Income (+$)
Interest Income809,670
Interest Expense-0
Other Finance Cost-809,670
Net Interest Income0
 
Pretax Income (+$)
Operating Income-51,980
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-424,200-51,980
EBIT - interestExpense = 0
-241,830
-241,830
Interest Expense0
Earnings Before Interest and Taxes (EBIT)0-424,200
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-424,200
Tax Provision--182,370
Net Income From Continuing Ops0-241,830
Net Income-241,830
Net Income Applicable To Common Shares-241,830
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net00
 

Technical Analysis of Nectar Lifesciences Limited
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Nectar Lifesciences Limited. The general trend of Nectar Lifesciences Limited is BULLISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Nectar Lifesciences Limited's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (14.3%) Bearish trend (-14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Nectar Lifesciences Limited.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 32.38 < 33.80 < 45.70.

The bearish price targets are: 29.26 > 28.80 > 27.80.

Tweet this
Nectar Lifesciences Limited Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Nectar Lifesciences Limited. The current mas is .

The long score for the Moving Averages is 8/14.
The longshort score for the Moving Averages is 2/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Nectar Lifesciences Limited Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Nectar Lifesciences Limited. The current macd is -1.78017503.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Nectar Lifesciences Limited price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Nectar Lifesciences Limited. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Nectar Lifesciences Limited price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Nectar Lifesciences Limited Daily Moving Average Convergence/Divergence (MACD) ChartNectar Lifesciences Limited Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Nectar Lifesciences Limited. The current adx is 33.24.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Nectar Lifesciences Limited shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Nectar Lifesciences Limited Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Nectar Lifesciences Limited. The current sar is 29.37.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Nectar Lifesciences Limited Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Nectar Lifesciences Limited. The current rsi is 34.30. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending up: The RSI is trending up. +1
Nectar Lifesciences Limited Daily Relative Strength Index (RSI) ChartNectar Lifesciences Limited Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Nectar Lifesciences Limited. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Nectar Lifesciences Limited price going down in the near term. -2
  • Trending up: The STOCH %K is trending up. +1
Nectar Lifesciences Limited Daily Stochastic Oscillator ChartNectar Lifesciences Limited Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Nectar Lifesciences Limited. The current cci is -82.83909866.

Nectar Lifesciences Limited Daily Commodity Channel Index (CCI) ChartNectar Lifesciences Limited Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Nectar Lifesciences Limited. The current cmo is -39.72177907.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Nectar Lifesciences Limited Daily Chande Momentum Oscillator (CMO) ChartNectar Lifesciences Limited Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Nectar Lifesciences Limited. The current willr is -87.64534884.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Nectar Lifesciences Limited Daily Williams %R ChartNectar Lifesciences Limited Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Nectar Lifesciences Limited.

Nectar Lifesciences Limited Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Nectar Lifesciences Limited. The current atr is 1.87726825.

Nectar Lifesciences Limited Daily Average True Range (ATR) ChartNectar Lifesciences Limited Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Nectar Lifesciences Limited. The current obv is 7,280,525.

Nectar Lifesciences Limited Daily On-Balance Volume (OBV) ChartNectar Lifesciences Limited Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Nectar Lifesciences Limited. The current mfi is 30.65.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Nectar Lifesciences Limited Daily Money Flow Index (MFI) ChartNectar Lifesciences Limited Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Nectar Lifesciences Limited.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-02STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-11-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-07WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-09STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-10STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-16STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-17STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-20STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-21ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-23STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-24STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-27RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-28MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-03RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-10MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-24SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-25WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-31MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-22MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-23MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-01STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-04WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-12MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-13BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-14RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-15MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

Nectar Lifesciences Limited Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Nectar Lifesciences Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5034.301
Ma 20Greater thanMa 5033.134
Ma 50Greater thanMa 10035.597
Ma 100Greater thanMa 20032.640
OpenGreater thanClose30.150
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Nectar Lifesciences Limited with someone you think should read this too:
  • Are you bullish or bearish on Nectar Lifesciences Limited? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Nectar Lifesciences Limited? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Nectar Lifesciences Limited

I send you an email if I find something interesting about Nectar Lifesciences Limited.


Comments

How you think about this?

Leave a comment

Stay informed about Nectar Lifesciences Limited.

Receive notifications about Nectar Lifesciences Limited in your mailbox!